Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Feb 24, 2017 (10 years ago)

Penicillin V Potassium Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Presence of Foreign Tablet/Capsule; Amoxicillin 500 mg was found in bottles of Penicillin V potassium 500 mg

Cause type: Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it. All cross-contamination recalls.

What was recalled

Penicillin V Potassium Tablets, USP 500 mg (800,000 units) 1000 count bottles, Rx Only, Distributed by: Citron Pharma LLC, East Brunswick, NJ --- NDC 57237-041-99

Affected NDC 57237-0041-99

Compare with the code on your package — it is the most precise check available.

Drug: Penicillin Category: Antibiotic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Penicillin V Potassium
NDC 57237-0041
500 mg/1 Tablet, Film Coated
Oral
Rising Health, LLC Rx
Recalling firm
Citron Pharma Llc
NDC code
57237-041-99
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0652-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Penicillin recalls

See all
Class II · Moderate risk

Bicillin L-A

cGMP Deviations: Products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-0701-10 D-0373-2024

Other cross-contamination recalls from 2017

All cross-contamination recalls
Class III · Low risk

Fluocinonide Gel USP

Cross contamination with other products: traces of Dapsone were found in the finished product.

Terminated Cross-contamination Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1279-1 D-0146-2018
Class II · Moderate risk

Nose to Toes Skin Antisepsis

Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products

Terminated Cross-contamination Sage Products Inc D-0411-2018